New York 2025 Session Status: Introduced

A11334 — Expands collaborative drug therapy management by pharmacists

Last action — In Assembly Committee

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Assembly
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the Assembly. Introduced May 11, 2026. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Prognosis

Not enough signal yet

Where this bill stands today.

Odds of enactment

Low

How often bills like it became law.

Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Summary

Expands collaborative drug therapy management by pharmacists; makes permanent certain provisions relating to authorizing pharmacists to perform collaborative drug therapy management with physicians in certain settings.

Bill Text

How this bill changes current law

1 change Share ↗

AI-generated reading aid from the bill's amendatory text — verify against the official bill.

This bill amends 1 section(s) of the New York Consolidated Laws: Section 6801-a of the education law.

  • Section 6801-a of the education law

    or with an on-site pharma- cy staffed by a licensed pharmacist , provided, however, that the provisions of sections two, three, and four of this act shall expire and be deemed repealed July 1, 2026 → (iii) a physician practice; or (iv) a facility licensed, certified, or otherwise authorized pursuant to article thirty-one or article thirty-two of the mental hygiene law, italics Patient consent to participate in collabora- tive drug therapy management may be obtained through the same process a facility currently utilizes to receive general written consent from patients to receive health care services.

    amended

Action History

  1. REFERRED TO HIGHER EDUCATION

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 218 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (218)

218 members have not signed on to this bill.

Show all 218 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does A11334 do?
Expands collaborative drug therapy management by pharmacists; makes permanent certain provisions relating to authorizing pharmacists to perform collaborative drug therapy management with physicians in certain settings.
Who sponsors A11334?
A11334 is sponsored by John T. McDonald III.
What is the current status of A11334?
This bill has been introduced in the Assembly. Introduced May 11, 2026. It must pass committee before a floor vote.
Where can I track A11334?
Track A11334 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on A11334

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of A11334

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →